CardioDx

Last updated: October 09, 2024

Deborah Kilpatrick, CEO
Deborah Kilpatrick, CEO
USA | Funding: $337.3M (+)

Website: http://www.cardiodx.com/

CardioDx is a cardiovascular genomic diagnostics company located in Redwood City, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure.